In this Issue:
On-demand PrEP with oral tenofovir/emtricitabine
Pragmatic open-label PrEP trial in MSM
Early ART and isoniazid prophylaxis in adults with high CD4 count
Tenofovir alafenamide vs. tenofovir disoproxil fumarate in HIV-1 infection
Abacavir and MI risk
Rosuvastatin vs. PI switch for hypercholesterolaemia
Statin reduces coronary noncalcified plaque volume
ART for preventing HAND
PEP with tenofovir/ emtricitabine + lopinavir/ ritonavir vs. maraviroc or raltegravir
Please login below to download this issue (PDF)